Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 12/20 | 1.00 |
| ▸ | ADORA1 | P30542 | 8/20 | 1.00 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.61 |
| ▸ | PI4KA | P42356 | 9/20 | 0.59 |
| ▸ | PI4K2B | Q8TCG2 | 9/20 | 0.59 |
| ▸ | PI4K2A | Q9BTU6 | 9/20 | 0.59 |
| ▸ | PI4KB | Q9UBF8 | 9/20 | 0.59 |
| ▸ | YTHDC1 | Q96MU7 | 1/20 | 0.56 |
| ▸ | CDK1 | P06493 | 1/20 | 0.55 |
| ▸ | EGFR | P00533 | 1/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7147821 | 0.98 | ADORA2A (0.96) | ADORA2AADORA1ADORA2BPI4KAPI4K2B | |
| SCHEMBL7140260 | 0.98 | ADORA2A (0.96) | ADORA2AADORA1ADORA2BPI4KAPI4K2B | |
| Furan SCHEMBL28428657 | 0.88 | ADORA2A (0.77) | ADORA2AADORA1ADORA2BPI4KAPI4K2B | |
| SCHEMBL4661802 | 0.81 | ADORA2A (0.65) | ADORA2AADORA1ADORA2BPI4KAPI4K2B | |
| SCHEMBL580610 | 0.78 | ADORA2A (0.64) | ADORA2AADORA1ADORA2BPI4KAPI4K2B | |
| SCHEMBL11222112 | 0.78 | ADORA2A (0.80) | ADORA2AADORA1ADORA2BPI4KAPI4K2B | |
| SCHEMBL28413958 | 0.77 | ADORA2A (0.62) | ADORA2AADORA1ADORA2BPI4KAPI4K2B | |
| SCHEMBL441875 | 0.77 | ADORA1 (0.62) | ADORA2AADORA1ADORA2BPI4KAPI4K2B | |
| SCHEMBL667204 | 0.77 | ADORA2A (0.62) | ADORA2AADORA1ADORA2BPI4KAPI4K2B | |
| SCHEMBL6883849 | 0.76 | ADORA2A (0.61) | ADORA2AADORA1ADORA2BPI4KAPI4K2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4388 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025137576-A1 | MULTIPLE SPECIFIC ANTIBODIES TARGETING CD19, CD20, AND/OR CD47 | NUTCRACKER THERAPEUTICS, INC. (US) | 2025-06-26 | — | — | WO | claimed |
| CN-120130364-A | Method for inducing and regenerating seedlings by using black lattice callus | 广西壮族自治区林业科学研究院 | 2025-06-13 | — | — | CN | claimed |
| CN-119639754-A | MRNA and synthesis method thereof, mRNA vaccine, capped RNA and in vitro transcription reaction liquid | 上海兆维医药科技有限公司 | 2025-03-18 | — | — | CN | claimed |
| WO-2025041085-A1 | DUAL NUCLEASE SYSTEMS FOR GENE EDITING, METHODS OF PRODUCING AND USING SAME | SPECIFIC BIOLOGICS INC. (CA) | 2025-02-27 | — | — | WO | claimed |
| CN-119404296-A | Semiconductor processing liquid, method for processing object to be processed, and method for manufacturing electronic device | 富士胶片株式会社 | 2025-02-07 | — | — | CN | claimed |
| CN-118108781-A | Capped polynucleotide, capped mRNA, capped composition, pharmaceutical protein, preparation method and application of capped polynucleotide and capped mRNA, pharmaceutical preparation | 上海兆维科技发展有限公司 | 2024-05-31 | — | — | CN | claimed |
| US-20240158433-A1 | COMPOSITIONS AND METHODS FOR SYNTHESIZING 5'-CAPPED RNAS | TRILINK BIOTECHNOLOGIES, LLC (US) | 2024-05-16 | — | — | US | claimed |
| US-20240140982-A1 | COMPOSITIONS AND METHODS FOR SYNTHESIZING 5'-CAPPED RNAS | TRILINK BIOTECHNOLOGIES, LLC (US) | 2024-05-02 | — | — | US | claimed |
| WO-2024064369-A1 | METHODS FOR AMPLIFYING NUCLEIC ACIDS | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2024-03-28 | — | — | WO | claimed |
| EP-4104687-B1 | COMPOSITIONS AND METHODS FOR SYNTHESIZING 5 -CAPPED RNAS | TRILINK BIOTECHNOLOGIES LLC (US) | 2024-01-31 | — | — | EP | claimed |
| EP-0846772-A1 | Multifunctional ligand system for cell-specific transfer of nucleic acid | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-06-10 | — | — | EP | claimed |
| US-5703224-A | Antiviral c-nucleoside derivatives | NIPPON SHINYAKU CO. LTD. (JP) | 1997-12-30 | — | — | US | claimed |
| US-5643744-A | CONDENSATION OF AMINO ACID AND A NUCLEIC ACID ADAPTER IN PRESENCE OF RIBOSOMES AND AROMATIC TERTIARY AMINE BUT NO ENERGY SOURCE SUCH AS ATP OR GTP | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1997-07-01 | — | — | US | claimed |
| WO-1997012993-A1 | MISMATCH REPAIR DETECTION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 1997-04-10 | — | — | WO | claimed |
| EP-0755254-A1 | PREVENTION AND TREATMENT OF ISCHEMIA-REPERFUSION AND ENDOTOXIN-RELATED INJURY USING ADENOSINE AND PURINO RECEPTOR ANTAGONISTS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1997-01-29 | — | — | EP | claimed |
| EP-0733630-A1 | NUCLEOSIDE DERIVATIVE | NIPPON SHINYAKU COMPANY, LIMITED (JP) | 1996-09-25 | — | — | EP | claimed |
| WO-1995026728-A1 | PREVENTION AND TREATMENT OF ISCHEMIA-REPERFUSION AND ENDOTOXIN-RELATED INJURY USING ADENOSINE AND PURINO RECEPTOR ANTAGONISTS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1995-10-12 | — | — | WO | claimed |
| WO-1995011685-A1 | 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS | SOUTHERN RESEARCH INSTITUTE (US) | 1995-05-04 | — | — | WO | claimed |
| EP-0646648-A1 | Method for producing polypeptide | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-04-05 | — | — | EP | claimed |
| WO-1991016333-A1 | 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS | SOUTHERN RESEARCH INSTITUTE (US) | 1991-10-31 | — | — | WO | claimed |